Skip to main content

Alx Oncology Holdings Inc

ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001810182

In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Alx Oncology Holdings Inc changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of ALXO: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders8675−11
Shares35.7M34.3M−1.40M (−3.9%)
Value$161.4M$257.5M+$96.2M (+59.6%)

New holders (11)

Institutions that held Alx Oncology Holdings Inc at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ALXO in Q2 2023
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC48,500$364.2K0.01%
Cornercap Investment Counsel Inc32,783$246.2K0.04%
Gsa Capital Partners LLP12,730$96.0K0.01%
MetLife Investment Management11,556$86.8K0.00%
Y-Intercept (Hong Kong) Ltd10,615$79.7K0.01%
Simplex Trading, LLC9,531$71.0K0.00%
Asset Dedication, LLC1,463$11.0K0.00%
Group One Trading, L.P.1,332$10.0K0.00%
Metropolitan Life Insurance Co1,201$9.02K0.00%
Red Tortoise LLC316$2.37K0.00%
Russell Investments Group, Ltd.269$2.02K0.00%

Sold out (22)

Institutions that held Alx Oncology Holdings Inc at the end of Q1 2023 and filed for Q2 2023 without it.